Long-Term Benefit of Empagliflozin on Life Expectancy in Patients With Type 2 Diabetes Mellitus and Established Cardiovascular Disease.
Document Type
Journal Article
Publication Date
10-9-2018
Journal
Circulation
Volume
138
Issue
15
Inclusive Pages
1599-1601
DOI
10.1161/CIRCULATIONAHA.118.033810
APA Citation
Claggett, B., Lachin, J., Hantel, S., Fitchett, D., Inzucchi, S., Woerle, H., George, J., & Zinman, B. (2018). Long-Term Benefit of Empagliflozin on Life Expectancy in Patients With Type 2 Diabetes Mellitus and Established Cardiovascular Disease.. Circulation, 138 (15). http://dx.doi.org/10.1161/CIRCULATIONAHA.118.033810
COinS